User profiles for P. Flamen
Patrick FlamenInstitut Jules Bordet Verified email at bordet.be Cited by 9785 |
Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
P Flamen, A Lerut, E Van Cutsem… - Journal of Clinical …, 2000 - ascopubs.org
… For local LN, the sensitivity of FDG-PET was lower than EUS (33% v 81%, respectively; P =
.027), but the specificity may have been higher (89% v 67%, respectively; P = not significant […
.027), but the specificity may have been higher (89% v 67%, respectively; P = not significant […
[PDF][PDF] Prevention and treatment of complications of selective internal radiation therapy: expert guidance and systematic review
…, L Bester, JI Bilbao, DM Coldwell, P Flamen… - …, 2017 - Wiley Online Library
Selective internal radiation therapy (or radioembolization) by intra‐arterial injection of radioactive
yttrium‐90‐loaded microspheres is increasingly used for the treatment of patients with …
yttrium‐90‐loaded microspheres is increasingly used for the treatment of patients with …
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic …
…, M Paesmans, JLV Laethem, P Flamen - Journal of clinical …, 2010 - ascopubs.org
… Grade 3 or 4 toxicities were recorded in six patients after FU monotherapy and in one
patient after radioembolization plus FU treatment (P = .10). Twenty-five of 44 patients received …
patient after radioembolization plus FU treatment (P = .10). Twenty-five of 44 patients received …
[HTML][HTML] Imaging in colorectal cancer: progress and challenges for the clinicians
E Van Cutsem, HMW Verheul, P Flamen, P Rougier… - Cancers, 2016 - mdpi.com
The use of imaging in colorectal cancer (CRC) has significantly evolved over the last twenty
years, establishing important roles in surveillance, diagnosis, staging, treatment selection …
years, establishing important roles in surveillance, diagnosis, staging, treatment selection …
[HTML][HTML] Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
P Flamen, E Van Cutsem, A Lerut, JP Cambier… - Annals of …, 2002 - Elsevier
… pre-CRT PET and the major response rate (P = 0.001): such response occurred in nine of 11
… (P = 0.002) than the extent of LN involvement seen on the pretreatment FDG-PET (P = 0.087…
… (P = 0.002) than the extent of LN involvement seen on the pretreatment FDG-PET (P = 0.087…
[HTML][HTML] Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab …
…, AH Brouwers, A Awada, EGE de Vries, P Flamen - Annals of oncology, 2016 - Elsevier
Background Only human epidermal growth factor receptor (HER)2 status determined by
immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) has been validated to …
immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) has been validated to …
[HTML][HTML] Bone health in cancer: ESMO clinical practice guidelines
Highlights • The clinical course of advanced cancer for many patients with bone metastases
can be transformed through optimum multidisciplinary management. • Bone-targeted agents …
can be transformed through optimum multidisciplinary management. • Bone-targeted agents …
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non …
…, GAMS van Dongen, K Muylle, P Flamen… - Radiotherapy and …, 2010 - Elsevier
Evidence is accumulating that radiotherapy of non-small cell lung cancer patients can be
optimized by escalating the tumour dose until the normal tissue tolerances are met. To further …
optimized by escalating the tumour dose until the normal tissue tolerances are met. To further …
[HTML][HTML] International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin …
Purpose A multidisciplinary expert panel convened to formulate state-of-the-art recommendations
for optimisation of selective internal radiation therapy (SIRT) with yttrium-90 ( 90 Y)-…
for optimisation of selective internal radiation therapy (SIRT) with yttrium-90 ( 90 Y)-…
Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on …
T Lerut, P Flamen, N Ectors, E Van Cutsem… - Annals of …, 2000 - journals.lww.com
Objective To assess the value of positron emission tomography with 18 fluorodeoxyglucose
(FDG-PET) for preoperative lymph node staging of patients with primary cancer of the …
(FDG-PET) for preoperative lymph node staging of patients with primary cancer of the …